Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.

Kowalski RP, Abdel Aziz S, Romanowski EG, Shanks RM, Nau AC, Raju LV.

JAMA Ophthalmol. 2013 Nov;131(11):1459-62. doi: 10.1001/jamaophthalmol.2013.5062.

3.

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.

Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK.

Ophthalmology. 2003 Aug;110(8):1593-600.

PMID:
12917179
4.

In vitro evaluations of topical agents to treat Acanthamoeba keratitis.

Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, Suzuki T, Inoue Y, Ohashi Y, Asari S, Iwatani Y.

Ophthalmology. 2014 Oct;121(10):2059-65. doi: 10.1016/j.ophtha.2014.04.013. Epub 2014 May 29.

PMID:
24880905
5.

The reculture technique: individualizing the treatment of Acanthamoeba keratitis.

Wysenbeek YS, Blank-Porat D, Harizman N, Wygnanski-Jaffe T, Keller N, Avni I.

Cornea. 2000 Jul;19(4):464-7.

PMID:
10928758
6.

Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba.

Lim L, Coster DJ, Badenoch PR.

Clin Exp Ophthalmol. 2000 Apr;28(2):119-24.

PMID:
10933775
7.

Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.

Polat ZA, Walochnik J, Obwaller A, Vural A, Dursun A, Arici MK.

Clin Exp Ophthalmol. 2014 Mar;42(2):151-8. doi: 10.1111/ceo.12120. Epub 2013 May 21.

PMID:
23601234
8.

Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.

Mafra CS, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Taguchi FM, Foronda AS, Carvalho FR, de Freitas D.

Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6363-72. doi: 10.1167/iovs.13-11990.

PMID:
23900604
9.

Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis.

Tu EY, Shoff ME, Gao W, Joslin CE.

JAMA Ophthalmol. 2013 May;131(5):595-600. doi: 10.1001/jamaophthalmol.2013.1644.

PMID:
23519403
10.

Phagocytosis affects biguanide sensitivity of Acanthamoeba spp.

Noble JA, Ahearn DG, Avery SV, Crow SA Jr.

Antimicrob Agents Chemother. 2002 Jul;46(7):2069-76.

11.

A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.

Vasseneix C, Gargala G, François A, Hellot MF, Duclos C, Muraine M, Benichou J, Ballet JJ, Brasseur G, Favennec L.

Cornea. 2006 Jun;25(5):597-602.

PMID:
16783150
12.

A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.

Elder MJ, Kilvington S, Dart JK.

Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1059-64.

PMID:
8125716
13.

Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.

Alizadeh H, Neelam S, Cavanagh HD.

Eye Contact Lens. 2009 Jan;35(1):1-5. doi: 10.1097/ICL.0b013e3181909ae6.

14.

The Development of Drugs against Acanthamoeba Infections.

Siddiqui R, Aqeel Y, Khan NA.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6441-6450. doi: 10.1128/AAC.00686-16. Print 2016 Nov. Review.

15.

Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.

Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Valladares B, Piñero JE, Lorenzo-Morales J.

Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2111-7. doi: 10.1007/s00417-013-2371-y. Epub 2013 May 19.

PMID:
23686225
16.

Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.

Bang S, Edell E, Eghrari AO, Gottsch JD.

Am J Ophthalmol. 2010 Jan;149(1):66-9. doi: 10.1016/j.ajo.2009.08.004. Epub 2009 Oct 28.

PMID:
19875089
17.
18.

Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro.

Tirado-Angel J, Gabriel MM, Wilson LA, Ahearn DG.

Curr Eye Res. 1996 Feb;15(2):225-8.

PMID:
8670733
19.

Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.

Hay J, Kirkness CM, Seal DV, Wright P.

Eye (Lond). 1994;8 ( Pt 5):555-63.

PMID:
7835453
20.

Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.

Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M.

Eye (Lond). 1996;10 ( Pt 4):413-21.

PMID:
8944089

Supplemental Content

Support Center